✦ LIBER ✦

Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation

✍ Scribed by Kaźmierczak, Maciej; Luczak, Magdalena; Lewandowski, Krzysztof; Handschuh, Luiza; Czyż, Anna; Jarmuż, Małgorzata; Gniot, Michał; Michalak, Michał; Figlerowicz, Marek; Komarnicki, Mieczysław

Book ID: 121599364
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 328 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-013-0725-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levels of soluble HLA-I and β2M in patie

Levels of soluble HLA-I and β2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy

✍ Albitar, M; Johnson, M; Do, K A; Day, A; Jilani, I; Pierce, S; Estey, E; Kantarj 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 221 KB

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

1144 POSTER Using Single-cell Network Pr

1144 POSTER Using Single-cell Network Profiling (SCNP) Signatures to Predict Response to Induction Therapy and Relapse Risk in Pediatric Patients With Acute Myeloid Leukemia (AML)

✍ A. Cesano; M. Westfall; D. Rosen; B. Louie; S. Meshinchi; T. Alonzo; R. Arceci; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A phase II trial of induction and consol

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

✍ Bouabdallah, R; Lefrère, F; Rose, C; Chaïbi, P; Harousseau, J-L; Vernant, J-P; C 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

High-dose imatinib mesylate combined wit

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

✍ Rea, D; Legros, L; Raffoux, E; Thomas, X; Turlure, P; Maury, S; Dupriez, B; Pign 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Bortezomib Added to Daunorubicin and Cyt

Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502

✍ Attar, E. C.; Johnson, J. L.; Amrein, P. C.; Lozanski, G.; Wadleigh, M.; DeAngel 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 230 KB